Image

Optimizing Bronchopulmonary Cancer Screening

Optimizing Bronchopulmonary Cancer Screening

Recruiting
50-74 years
All
Phase N/A

Powered by AI

Overview

The aim of this study is to evaluate the feasibility of performing a first screening for bronchopulmonary cancer by thoracic scanner in a French cohort within a dedicated, effective and structured network in the pilot centers participating in the study.

Description

The organization of bronchopulmonary cancer screening in the Ile de France region, within the Mutualists and its affiliated health centers, is based on a clear, simple and functional process:

  • Definition of eligibility criteria for screening, based on those of the NELSON study,
  • Referral and consultation by a health center physician trained in these criteria,
  • Referral and performance of a chest Computer Tomography Scanner (CTscan) according to the same recommendations,
  • Structured centralized reading and interpretation of CTscan images,
  • Referral to a multidisciplinary team (CITT), if bronchopulmonary cancer is suspected,
  • Referral to a tobacco unit in a health center for smokers who have not stopped smoking,
  • Organization of follow-up and continuation of the screening program.

Eligibility

Inclusion Criteria:

  • Participant aged 50 to 74.
  • Resident in the Île-de-France region.
  • Active smoker or quit smoker for 10 years or less:
    1. more than 10 cigarettes a day for more than 30 years,
    2. more than 15 cigarettes a day for more than 25 years.
  • The participant has been informed and has signed the consent form.
  • Social Security System affiliation.
  • Willingness to participate in a smoking cessation program, if currently smoking.

Exclusion Criteria:

  • Active cancer or a history of cancer in remission for less than 5 years (except basal cell carcinoma of th skin or epithelioma in situ of the uterine cervix).
  • Presence of symptoms suggestive of bronchopulmonary cancer. Participants with these symptoms require immediate diagnostic investigations and are therefore not eligible for screening.
  • Weight >= 140 kg.
  • Severe comorbidity contraindicating therapeutic options or invasive thoracic diagnostic investigations.
  • Inability to climb two flights of stairs without stopping.
  • A thoracic CTscan performed within the previous year.
  • Persons deprived of liberty or under guardianship.
  • Impossibility to undergo the medical monitoring of the trial for geographical, social or psychological reasons.

Study details
    Bronchopulmonary Disease
    Diagnoses Disease

NCT06439901

Institut Curie

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.